New indications for 6-azauridine treatment in man. A review
- 1 March 1972
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 4 (2), 77-81
- https://doi.org/10.1007/bf00562501
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Teratogenic effect of 6‐azauridine in ratsTeratology, 1971
- Cancer Chemotherapy with Purine and Pyrimidine AnaloguesAnnual Review of Pharmacology, 1967
- Increase of uridine kinase activity after infection of cells with vaccinia and rous sarcoma virusesBiochemical and Biophysical Research Communications, 1964
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963
- TREATMENT OF MYCOSIS FUNGOIDES WITH 6-AZAURACILRIBOSIDEThe Lancet, 1963
- Chromosome Changes Caused by 6-Azauridine During Treatment of Acute Myeloblastic LeukaemiaBMJ, 1963
- THE URICOSURIA AND OROTIC ACIDURIA INDUCED BY 6-AZAURIDINE*JCI Insight, 1961
- Effect of some Metabolic Inhibitors on Antibody FormationNature, 1961
- Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracilBiochimica et Biophysica Acta, 1958
- Studies of bacterial resistance to 6-azauracil and its ribosideBiochimica et Biophysica Acta, 1957